文献速递神经肿瘤

合成MRI在鉴别IDH突变型弥漫性胶质瘤中的价值及其与T2-FLAIR错配征的比较

Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign.
PubMed 文献 · J Neurooncol · 2024-08-12

本研究纳入20例新诊断非强化IDH突变型弥漫性胶质瘤患者,术前接受合成MRI(QRAPMASTER序列),评估T2-FLAIR错配征并测量肿瘤T1、T2及质子密度值。结果显示星形细胞瘤的T1、T2、PD值均显著高于少突胶质细胞瘤,病灶T1截断值1580 ms可完全鉴别两者(AUC=1.00),优于常规T2-FLAIR错配征。

要点

  • 合成MRI定量测量肿瘤T1、T2、PD值可鉴别IDH突变型星形细胞瘤与少突胶质细胞瘤。
  • 星形细胞瘤T1、T2、PD值均显著高于少突胶质细胞瘤(p<0.0001、<0.0001、0.0154)。
  • 病灶T1截断值1580 ms完全鉴别两者(AUC=1.00),优于T2-FLAIR错配征(AUC=0.833)。

核心结论

  • 合成MRI定量评估非强化IDH突变型弥漫性胶质瘤,对星形细胞瘤与少突胶质细胞瘤的鉴别优于常规T2-FLAIR错配征。
  • 合成MRI测量T1和T2值可改善IDH突变型弥漫性胶质瘤的鉴别。

研究设计与样本

  • 本研究纳入20例新诊断非强化IDH突变型弥漫性胶质瘤患者,术前接受合成MRI(QRAPMASTER序列)检查。
  • 两名独立评估者评估术前常规MR图像以确定T2-FLAIR错配征存在与否,并用合成MRI测量肿瘤病灶T1、T2和质子密度(PD)值。
  • 采用受试者工作特征(ROC)曲线分析评估诊断性能。

主要发现

  • 病理诊断包括IDH突变型星形细胞瘤12例和IDH突变型伴1p/19q共缺失的少突胶质细胞瘤8例。
  • T2-FLAIR错配征诊断星形细胞瘤的敏感度为66.7%、特异度为100%(AUC=0.833)。
  • 星形细胞瘤的T1、T2和PD值均显著高于少突胶质细胞瘤(p<0.0001、<0.0001和0.0154)。
  • 病灶T1截断值1580 ms可完全鉴别星形细胞瘤与少突胶质细胞瘤(AUC=1.00)。

关键数值与推荐

  • T2-FLAIR错配征诊断星形细胞瘤的敏感度为66.7%、特异度为100%(AUC=0.833)。
  • 星形细胞瘤与少突胶质细胞瘤的T1、T2和PD值比较p值分别为<0.0001、<0.0001和0.0154。
  • 病灶T1截断值1580 ms鉴别星形细胞瘤与少突胶质细胞瘤的AUC=1.00。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The T2-FLAIR mismatch sign is a characteristic imaging biomarker for astrocytoma, isocitrate dehydrogenase (IDH)-mutant. However, investigators have provided varying interpretations of the positivity/negativity of this sign given for individual cases the nature of qualitative visual assessment. Moreover, MR sequence parameters also influence the appearance of the T2-FLAIR mismatch sign. To resolve these issues, we used synthetic MR technique to quantitatively evaluate and differentiate astrocytoma from oligodendroglioma. METHODS: This study included 20 patients with newly diagnosed non-enhanced IDH-mutant diffuse glioma who underwent preoperative synthetic MRI using the Quantification of Relaxation Times and Proton Density by Multiecho acquisition of a saturation-recovery using Turbo spin-Echo Readout (QRAPMASTER) sequence at our institution. Two independent reviewers evaluated preoperative conventional MR images to determine the presence or absence of the T2-FLAIR mismatch sign. Synthetic MRI was used to measure T1, T2 and proton density (PD) values in the tumor lesion. Receiver operating characteristic (ROC) curve analysis was performed to evaluate the diagnostic performance. RESULTS: The pathological diagnoses included astrocytoma, IDH-mutant (n = 12) and oligodendroglioma, IDH-mutant and 1p/19q-codeleted (n = 8). The sensitivity and specificity of T2-FLAIR mismatch sign for astrocytoma were 66.7% and 100% [area under the ROC curve (AUC) = 0.833], respectively. Astrocytoma had significantly higher T1, T2, and PD values than did oligodendroglioma (p < 0.0001, < 0.0001, and 0.0154, respectively). A cutoff lesion T1 value of 1580 ms completely differentiated astrocytoma from oligodendroglioma (AUC = 1.00). CONCLUSION: Quantitative evaluation of non-enhanced IDH-mutant diffuse glioma using synthetic MRI allowed for better differentiation between astrocytoma and oligodendroglioma than did conventional T2-FLAIR mismatch sign. Measurement of T1 and T2 value by synthetic MRI could improve the differentiation of IDH-mutant diffuse gliomas.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Onishi S, Yamasaki F, Akiyama Y, et al. Usefulness of synthetic MRI for differentiation of IDH-mutant diffuse gliomas and its comparison with the T2-FLAIR mismatch sign. J Neurooncol. 2024. PMID: 39133381. doi:10.1007/s11060-024-04794-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。